Table 2.
Clinical and Diagnostic Data
| Ocular Features | No. of Eyes (%) |
|---|---|
| Best corrected visual acuity (BCVA) | |
| Worse than 20/200 | 24/26 (92.3) |
| 20/40 to 20/200 | 2/26 (7.7) |
| Pattern of infiltration | |
| Reticular | 11/24 (45.8) |
| Satellite | 10/24 (41.7) |
| Multifocal | 2/24 (8.3) |
| Total infiltration | 1/24 (4.2) |
| Maximal diameter of infiltration area (mm) (mean ± SD) | 5.56 ± 1.94 |
| Depth of infiltration | |
| Anterior to mid stroma | 11/23 (47.8) |
| Posterior stroma | 12/23 (52.2) |
| Presence of epithelial defect | 23/26 (88.5) |
| Presence of hypopyon | 14/26 (53.8) |
| Diagnostic laboratory | |
| Positive culture | 1/25 (4) |
| Positive PCR | 4/25 (16) |
| Positive culture, genus and species confirmed by PCR | 20/25 (80) |
| PIAI injection | 17/26 (65.4) |
| In globe salvage case | 7/17 (41.2) |
| In globe removal case | 10/17 (58.8) |
| Surgical interventions | |
| Corneal biopsy | 10/26 (38.5) |
| TPK | 21/26 (80.7) |
| Evisceration or enucleation | 15/26 (57.7) |
| Treatment outcome | |
| Globe salvage | 11/26 (42.3) |
| Globe removal | 15/26 (57.7) |